Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000022270
JPRN-UMIN000022270
Completed
未知

Evaluation of the effects and predictive factors of double dose of adalimumab for the patients with Crohn's disease - ADA2 study

Saitama Medical Center0 sites7 target enrollmentJuly 1, 2016
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCrohn&#39s disease

Overview

Phase
未知
Intervention
Not specified
Conditions
Crohn&#39
Sponsor
Saitama Medical Center
Enrollment
7
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 1, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •refractory patients for adalimumab

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
The study of predictive factors for the effect of Salmeterol/Fluticasone combination(SFC) on the patients with obstructive pulmonary dysfunction.obstructive pulmonary dysfunction
JPRN-UMIN000010276Kagoshima university pulmonary medicine60
Active, not recruiting
Phase 1
Evaluation of predictive Factors for the Effectivity of Aromatase Inhibitor Therapy - Offene, prospektive, multizentrische Phase IV-Studie zur Untersuchung des Einflusses von pharmakogenetischen Markern auf die Wirksamkeit und Nebenwirkungsrate bei postmenopausalen, steroidhormonrezeptorpositiven Mammakarzinomspatientinnen, die mit Letrozol behandelt werden. - PreFace
EUCTR2008-004874-42-DEInstitut für Frauengesundheit GmbH3,500
Active, not recruiting
Not Applicable
A predictive study of determining factors affecting success of hip fracture surgery within 24 ,48 and 72 hoursHip fractures including fracture neck femur, intertrochanteric femoral fracture, subtrochanteric femoral fracturepredictive factors , hip fracture surgery , early surgery
TCTR20240318006FACULTY OF MEDICINE VAJIRA HOSPITA390
Recruiting
Phase 2
The efficacy, safety, and the predictive factors of efficacy of low dose Lenalidomide plus Dexamethasone consolidation therapy followed by very low dose Lenalidomide maintenance therapy for multiple myeloma.multiple myeloma
JPRN-UMIN000007785ational Hospital Organization Disaster Medical Center35
Recruiting
Not Applicable
The efficacy, safety, and the predictive factors of efficacy of Bird therapy
JPRN-UMIN000013959ational Hospital Organization Disaster Medical Center35